RE: Paul LOADMAN, Professor of Pharmacokinetics23 Mar 2024 12:08
I’m not sure the new shares will be overly churned. I suspect a lot of the private investors that took part in the placing are long term investors that want to bring their average down- or would have sold in the high 50’s their current shares before picking up a new batch at 50p. The CLR is more of a concern however in the short term.